• DOI:10.3390/ijms18020273
• Corpus ID: 4862419

From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation

@article{Howick2017FromBT,
  title={From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation},
  author={Ken Howick and Brendan T. Griffin and John F. Cryan and Harri{\"e}t Schellekens},
  journal={International Journal of Molecular Sciences},
  year={2017},
  volume={18}
}

• K. Howick, B. Griffin, +1 author H. Schellekens
• Published 27 January 2017
• Biology, Psychology
• International Journal of Molecular Sciences

Ghrelin is the only known peripherally-derived orexigenic hormone, increasing appetite and subsequent food intake. The ghrelinergic system has therefore received considerable attention as a therapeutic target to reduce appetite in obesity as well as to stimulate food intake in conditions of anorexia, malnutrition and cachexia. As the therapeutic potential of targeting this hormone becomes clearer, it is apparent that its pleiotropic actions span both the central nervous system and peripheral organs. Despite a wealth of research, a therapeutic compound specifically targeting the ghrelin system for appetite modulation remains elusive although some promising effects on metabolic function are emerging. This is due to many factors, ranging from the complexity of the ghrelin receptor (Growth Hormone Secretagogue Receptor, GHSR-1a) internalisation and heterodimerization, to biased ligand interactions and compensatory neuroendocrine outputs. Not least is the ubiquitous expression of the GHSR-1a, which makes it impossible to modulate centrally-mediated appetite regulation without encroaching on the various peripheral functions attributable to ghrelin. It is becoming clear that ghrelin’s central signalling is critical for its effects on appetite, body weight regulation and incentive salience of food. Improving the ability of ghrelin ligands to penetrate the blood brain barrier would enhance central delivery to GHSR-1a expressing brain regions, particularly within the mesolimbic reward circuitry.